Blood Advances in a Different Vein

Blood Advances in a Different Vein

Research from recent issues of Blood Advances

Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma

Achievement of measurable residual disease (MRD) negativity is associated with significant improvements in progression-free survival (PFS) and overall survival (OS) in patients with multiple...

Azacitidine Maintenance Fails to Improve Post-Transplant Outcomes in High-Risk AML and MDS

Maintenance treatment with single-agent azacitidine at a dose of 32 mg/m2 daily for five days did not lead to improved survival in patients with...

Registry Analysis Finds Patients With Hematologic Malignancies Are Highly Vulnerable to COVID-19

In an analysis of data from the first 250 patients enrolled in the ASH Research Collaborative (ASH RC) COVID-19 Registry for Hematology, researchers found...

Rethinking Autoimmune Neutropenia in Children

Authors of a registry analysis published in Blood Advances have identified two distinct autoimmune neutropenia entities in children who present with apparent primary autoimmune...

Does Blood Group Affect Risk of Bleeding Events or Bleeding Severity?

According to research published in Blood Advances, people who experience bleeding of unknown causes are 48% more likely to have blood group O, compared...

Normal Results on D-Dimer Testing Can Safely Rule out Deep Vein Thrombosis

A simplified approach of an initial stand-alone D-dimer test followed by a single whole-leg compression ultrasound (CUS) in D-dimer positive patients can effectively and...

Mogamulizumab Demonstrates Antitumor Activity in Adult T-Cell Leukemia/Lymphoma

Nearly two-thirds of patients with adult T-cell leukemia-lymphoma (ATLL) responded to treatment with mogamulizumab as a single agent or as part of a treatment...

How Common Is Venous Thromboembolism in Patients Hospitalized With COVID-19?

Reports have suggested that venous thromboembolism (VTE) is a frequent complication of COVID-19 infection, and patients are at an increased thrombotic risk even with...

Rivaroxaban and Standard Anticoagulants Safe, Reduce Clot Burden in Most Children With CVC-VTE

In most children with central venous catheter-related venous thromboembolism (CVC-VTE), treatment with rivaroxaban or other standard anticoagulants reduced clot burden, according to results from...

Study Supports Earlier, More Frequent Use of Hospice in Older Patients With Hematologic Malignancies

Earlier and more frequent hospice use may be associated with a lower probability of inpatient death and a reduction in aggressive care at end...
Advertisement

Current Issue

Mid-January 2021 Annual Meeting Edition

This issue features highlights from the 2020 ASH Annual Meeting, a look at doctor-patient gifting customs around the world, and more.

Block title